Abstract
A great variety of therapies are available for the treatment of locally advanced prostatic carcinoma with or without metastases. While hormone withdrawal in itself is no new approach to such treatment and has been practised in the form of orchiectomy, estrogen or antiandrogen therapy and irradiation for many years, it can also be effected by applying the luteinizing hormone-releasing hormone (LH-RH) analogues of the endogenous decapeptide LH-RH as isolated and synthesized by Schally in 1971 [2, 3, 5, 9, 12, 13, 15].
This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
References
Allen JM, Kerle DJ, Ware H, Doble A, Williams G, Bloom SR (1983) Combined treatment with ketoconazone and luteinising-hormone releasing-hormone analogue: a novel approach to resistant progressive prostatic cancer. Br Med J 287: 1766
Borgmann V, Hardt W, Schmidt-Gollwitzer M, Adenauer H, Nagel R (1982) Sustained suppression of testosterone production by the luteinising-hormone releasing-hormone agonist buserelin in patients with advanced prostate carcinoma. A new therapeutic approach? Lancet: 1097
Borgmann V, Nagel R, Al-Abadi H, Schmidt-Gollwitzer M (1983) Treatment of prostatic cancer with LH-RH analogues. Prostate 4: 553
Faure N, Lemay A, Laroche B, Robert G, Plante R, Jean C, Thabet M, Roy R, Fazekas ATA (1983) Preliminary results on the clinical efficacy and safety of androgen inhibition by a LH-RH agonist alone or combined with an antiandrogen in the treatment of prostatic carcinoma. Prostate 4: 601
Faure N, Lemay A, Tolis G, Labrie F, Belanger A, Fazekas ATA (1984) Buserelin therapy for prostatic carcinoma. In: Labrie F, Belanger A, Dupont A (eds) LH-RH and its analogues. Elsevier Science Publishers Amsterdam, pp 337
Labrie R, Dupont A, Belanger A, Lefebre FA, Cusan L, Monfette G, Laberge JG, Emonds JP, Raynaud JP, Husson JM, Fazekas ATA (1983) New hormonal treatment in cancer of the prostate: combined administration of an LH-RH agonist and an antiandrogen. J Steroid Biochem 19: 999
Leistenschneider W, Nagel R (1980) Cytological and DNA-cytophotometric monitoring of the effects of therapy in conservatively treated prostatic carcinoma. Scand J Urol Nephrol [Suppl] 55: 197 Leistenschneider W, Nagel R (1984) Praxis der Prostatazytologie. Springer; Berlin-Heidelberg -New York-Tokyo English edition (1984) Atlas of prostatic cytology. Springer; Berlin-Heidelberg-New York -Tokyo
Leistenschneider W, Nagel R (1983) Estracyt-Therapie beim fortgeschrittenen Prostatakarzinom: Ergebnisse einer klinisch und zytologisch kontrollierten, prospektiven Studie. Akt Urol 14: 127
Redding RW, Schally AV (1981) Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6-analogue of luteinizing hormone-releasing hormone agonists. Proc Natl Acad Sci USA 78: 6509
Sandow J (1983) The regulation of LH-RH action at the pituitary and gonadal receptor level: a review. Psychoneuroendocrinology 8: 277
Sandow J (1983) Clinical applications of LH-RH and its analogues. Clin Endocrinol (Oxf) 18: 571
Santen RJ, Demers LM, Max DT, Smith J, Stein BS, Glode LM (1984) Long-term effects of administration of a gonadotropin-releasing hormone superagonist analogue in men with prostatic carcinoma. J Clin Endocrinol Metab 58: 397
Schally AV, Arimura Y, Baba RMG, Nair H, Matsuo T, Redding W, Debeljuk L, White WF (1971) Isolation and properties of the FSH- and LH-releasing hormone. Biochem Biophys Res Commun 43: 393
Waxman JH, Wass J AH, Hendry WF, Whitfield HN, Besser GM, Malpas JS, Oliver RTD (1983) Treatment with gonadotropin releasing hormone analogues in advanced prostatic cancer. Br Med J 286: 1309
Wenderoth UK, Jacobi GH (1983) Gonadotropin-releasing hormone analogues for palliation of carcinoma of the prostate. A new approach to the classical concept. World J Urol 1: 40
Zetterberg A, Esposti PL (1979) Cytophotometric DNA-analysis of aspirated cells from prostatic carcinoma. Acta Cytol 20: 46
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Nagel, R., Al-Abadi, H., Borgmann, V. (1988). Results of the Treatment of Locally Advanced Prostatic Carcinoma with LH-RH Analogues. In: Höffken, K. (eds) LH-RH Agonists in Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73530-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-73530-1_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73532-5
Online ISBN: 978-3-642-73530-1
eBook Packages: Springer Book Archive